CymitQuimica logo

CAS 1010412-80-2

:

Formel:C32H37NO6
InChl:InChI=1S/C32H37NO6/c1-32(2,3)24-12-10-23(11-13-24)29-27-8-6-7-9-28(27)33(30(29)31(34)35)21-22-18-25(38-16-14-36-4)20-26(19-22)39-17-15-37-5/h6-13,18-20H,14-17,21H2,1-5H3,(H,34,35)
InChI Key:OIDYMQICWGYEDR-UHFFFAOYSA-N
SMILES:CC(C)(C)C1=CC=C(C=C1)C2=C(N(C3=CC=CC=C32)CC4=CC(=CC(=C4)OCCOC)OCCOC)C(=O)O
4 Produkte gefunden.
  • GSK376501A

    CAS:
    Formel:C32H37NO6
    Reinheit:97%
    Molekulargewicht:531.6393

    Ref: IN-DA01EOP3

    1mg
    646,00€
    5mg
    1.417,00€
    25mg
    2.272,00€
  • GSK376501A

    CAS:
    GSK376501A
    Formel:C32H37NO6
    Reinheit:99.5%
    Molekulargewicht:531.64

    Ref: 54-BUP20523

    1mg
    241,00€
    5mg
    554,00€
    10mg
    821,00€
    25mg
    1.189,00€
    50mg
    1.598,00€
    100mg
    2.166,00€
  • GSK376501A

    CAS:

    GSK376501A is an ethylene oxide-based compound that is used in the synthesis of aryl halides. GSK376501A has been used as an intermediate for the synthesis of a number of potential therapeutic agents, such as anti-diabetic drugs. This compound has also been shown to be a nucleophilic agent and can be used in process development. GSK376501A is also effective at inhibiting glucose release from pancreatic cells in vitro, suggesting it may have potential therapeutic use in diabetes treatment.

    Formel:C32H37NO6
    Reinheit:Min. 95%
    Molekulargewicht:531.6 g/mol

    Ref: 3D-KQB41280

    5mg
    1.284,00€
    10mg
    2.000,00€
    25mg
    3.750,00€
    50mg
    5.999,00€
  • GSK376501A

    CAS:
    GSK376501A is a selective and effective modulator of peroxisome proliferator-activated receptor γ (PPARγ) for the study of type 2 diabetes.
    Formel:C32H37NO6
    Reinheit:97.71% - >99.99%
    Farbe und Form:White Solid
    Molekulargewicht:531.64